What Genome Medical does

Genome Medical is a telehealth-enabled genetics care delivery company headquartered in South San Francisco, California. Founded in 2016, the company operates a nationwide telegenomics platform delivering genetic counseling, genetic test ordering, peer-to-peer provider support, clinical trial matching, and patient recruitment services across all 50 U.S. states. The company serves four primary customer segments: hospitals and health systems seeking to expand access to genetic services without building in-house capacity; life sciences organizations pursuing patient recruitment and clinical trial matching for genetic therapies; genetic testing laboratories requiring pre- and post-test counseling support; and individual patients and families navigating rare disease diagnoses—more than 50% of whom present with a rare disease indication. Genome Medical employs a clinical team of 35+ genetic counselors, medical geneticists, and physicians with an average of 10+ years of clinical experience and has delivered over 250,000 genetic counseling sessions with a 96% patient satisfaction rating.

The core technology is a HIPAA-compliant virtual medical practice platform that integrates telehealth (phone or video) genetic counseling, test ordering integrated with most major genetic testing laboratories, and a patient portal for scheduling and records management. Genome Medical acquired GeneMatters in August 2021 and operates it as a wholly-owned subsidiary. Revenue is generated through multiple streams: insurance billing as an in-network provider with major commercial health plans (Aetna, Anthem, BlueCross BlueShield, Cigna, United Healthcare); self-pay genetic counseling sessions at $250 each; and partnership agreements with health systems, genetic testing laboratories, and biopharmaceutical companies for sponsored testing programs, patient recruitment, and clinical trial feasibility analysis. Government-affiliated insurance (Medicaid, Medicare, Tricare) is not accepted.

Genome Medical has raised approximately $195 million across eight disclosed funding rounds from 2016 through 2024, including a $60 million Series C in August 2021 and an approximately $75.3 million exempt securities offering in September 2024. Notable institutional investors include Canaan Partners, Casdin Capital, Echo Health Ventures, Samsung Catalyst Fund, GE Ventures, Kaiser Permanente Ventures, Illumina Ventures, Google Ventures, and Amgen Ventures. The 2024 capital is allocated to expand services across the U.S. and into Canada, scale operations, enhance genetic counseling capacity, and develop partnerships with health systems, laboratories, and biopharmaceuticals. Leadership includes CEO Jill Davies alongside founders Lisa Alderson, Robert Green, and Randy Scott (Chairman).

Name

Genome Medical

Legal name

Genome Medical, Inc.

Website

https://genomemedical.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Genome Medical is a telehealth-enabled genetics care delivery company providing genetic counseling, test ordering, clinical trial matching, and patient recruitment across all 50 U.S. states, serving hospitals, life sciences organizations, genetic testing labs, and individual patients.

Ownership category

akta.pro rank

Product category

Telehealth Genetic Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK)

akta.pro secondary industries

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Population Genomics & Preventive Precision Health Programs (HLAAANAL)

Keywords

• Telehealth genetic counseling
• Genomic medicine services
• Genetic test ordering
• Clinical trial matching
• Rare disease diagnostics

Headquarters

HQ city

South San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Genetic Counseling Services: Genome Medical bills insurance for genetic counseling sessions as an in-network provider with most commercial health insurance plans. Patients can also self-pay at $250 per session. The company also offers sponsored testing programs for life sciences partners, generating revenue through partnership agreements with health systems, genetic testing labs, and biopharmaceutical companies for patient recruitment and clinical trial matching services.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Genome Medical is a telehealth-enabled genetics care delivery company providing virtual genetic counseling, genetic test ordering, and clinical trial matching services across all 50 U.S. states. The company delivers board-certified genetic counseling sessions via phone or video, integrates with major genetic testing laboratories to order tests, and partners with life sciences organizations to recruit patients for clinical trials. Its core clientele includes patients with rare diseases, hospitals and health systems, genetic testing laboratories, and biopharmaceutical companies.

Product overview

Genome Medical is a telehealth-enabled genetics care delivery company offering a platform of genetic services. The core offerings include Genetic Counseling (telehealth sessions with board-certified genetic counselors), Genetic Test Ordering (ordering tests through partnered labs), Clinical Trial Services (matching patients to trials), Peer-to-Peer Genetics Support (provider-to-provider consultation), Patient Recruitment, and Sponsored Testing Programs. The company acquired GeneMatters in 2021 to expand telehealth genetic counseling capacity. Services are delivered via telehealth across all 50 U.S. states, supported by a patient portal for scheduling and records. The company serves patients, healthcare providers, hospitals/health systems, life sciences organizations, and genetic testing laboratories.

Differentiator

Problem solved

Functional benefit

Brands

• GeneMatters: A telehealth genetic counseling platform acquired by Genome Medical in 2021, now operating as a Genome Medical company.

Products and services

• Genetic Counseling Telehealth-enabled genetic counseling sessions delivered by board-certified genetic counselors via phone or video across all 50 U.S. states, helping patients understand genetic testing options, interpret test results, and assess hereditary risk.
• Genetic Test Ordering Service in which Genome Medical providers order medically appropriate genetic tests for U.S.-based patients, partnering with major genetic testing laboratories so patients and providers can work with their lab of choice.
• Clinical Trial Services Clinical trial matching and recruitment service that identifies eligible patients based on genetic criteria, notifies them of relevant trial opportunities, and supports clinical trial feasibility analysis for sponsors.
• Peer-to-Peer Genetics Support Provider-to-provider genetics consultation service that connects healthcare providers with Genome Medical genetics experts for support with testing decisions, interpretation of results, and patient care guidance.
• Patient Recruitment Service for life sciences partners that identifies and recruits eligible patients based on genetic criteria, facilitating and accelerating clinical trial enrollment.
• Sponsored Testing Programs Programs that expand genetic testing access, accelerate diagnosis, or confirm eligibility for clinical trials, typically delivered in partnership with life sciences organizations.
• GeneMatters Telehealth genetic counseling solutions platform acquired by Genome Medical in August 2021, now operating as a Genome Medical subsidiary brand to expand clinical capacity for genetic counseling services.
• Family Testing Program Genetic counseling and testing program for individuals with relatives who have a known genetic condition; includes initial consultation, saliva-based at-home testing kit, and results review with a genetic counselor.

Quantifiable outcome

• Patients can meet with a genetic counselor within one week — compared to months-long waits typical of in-person genetics appointments.
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered minor and core.

• PharmingminorStrategic or Co-development Partner · 1 January 2024Pharming, a biopharmaceutical company developing therapies for rare diseases, participated in a joint webinar with Genome Medical titled 'Bridging the Diagnosis Gap for Rare Disease Therapies'. Dr. Heather McLaughlin, Senior Director of Molecular Diagnostics at Pharming, was a featured speaker. Genome Medical has also published a case study with Pharming about how genetic counseling boosts engagement for rare disease diagnosis.
• Tenaya TherapeuticsminorStrategic or Co-development Partner · 1 January 2024Tenaya Therapeutics, a company developing gene therapies for rare cardiac conditions, participated in a joint webinar with Genome Medical. Jeff Haroldson, Executive Director of Medical Affairs at Tenaya, was a featured speaker discussing genetic testing programs for individuals and families with hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC).
• Genetic Testing LaboratoriescoreStrategic or Co-development PartnerGenome Medical partners with most major genetic testing laboratories, allowing patients and providers to work with their lab of choice. The company integrates genetic counseling and test ordering services with laboratory testing workflows, supporting appropriate test selection, ordering, and result interpretation.
• Hospitals and Health SystemscoreStrategic or Co-development PartnerGenome Medical partners with hospitals and health systems — from large multi-site systems to smaller community hospitals — to help them reach more patients with genetic services. The partnership enables health systems to expand genetics care delivery without building in-house capacity.
• Life Sciences OrganizationscoreStrategic or Co-development PartnerGenome Medical partners with life sciences organizations for product development, product launch, and market expansion initiatives. Services include patient recruitment for clinical trials, sponsored testing programs, clinical trial matching, and clinical trial feasibility analysis, helping identify and understand patient populations.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Helix: Helix operates a population genomics platform with health-system partnerships for preventive genomics programs. Its model intersects with Genome Medical's life sciences and health-system service offerings.
• PreventionGenetics (part of Exact Sciences): PreventionGenetics is a clinical DNA testing laboratory offering rare-disease and hereditary cancer tests with clinical support. It is comparable as a genetic testing lab serving the same clinical specialties as Genome Medical.
• 23andMe: 23andMe is a consumer genetics company with a telehealth genetic counseling arm (Lemonaid Health integration) and a large genotype-phenotype database. It overlaps with Genome Medical on direct-to-patient genetic services and large-scale genetic data assets.
• Blueprint Genetics: Blueprint Genetics is a specialty genetics lab focused on inherited disease diagnostics with clinical interpretation services. It competes in the rare-disease genetic testing and clinical support market served by Genome Medical.

Broad incumbents

• Natera: Natera is a genetic testing company focused on reproductive health, oncology, and organ transplantation with growing clinical services and patient support functions. It is comparable as a major lab-adjacent clinical services provider.
• Invitae: Invitae is a large-scale genetic testing laboratory offering hereditary cancer, rare disease, and reproductive health testing with integrated clinical services. As an established incumbent, it competes with Genome Medical across multiple test categories where counseling accompanies results.
• Myriad Genetics: Myriad is an established molecular diagnostics company with hereditary cancer, prenatal, and pharmacogenomic testing. Its integrated test-plus-services model overlaps with Genome Medical's hospital and life sciences partnerships.
• Quest Diagnostics (Genetic Counselors / Quiete): Quest Diagnostics is a national reference lab that has expanded into genetic counseling services for its hereditary and reproductive genetic testing portfolio. It represents a large incumbent that could bundle or compete with telegenetic counseling offerings.

Direct peers

• GeneDx (formerly Sema4): GeneDx is a clinical genomics lab delivering rare-disease and pediatric genetic testing with clinical interpretation and counseling support. It overlaps directly with Genome Medical in the rare-disease genetic services market.
• Color Health: Color Health combines genetic testing with virtual genetic counseling and clinical services delivered to patients, employers, and health systems. It is the closest direct peer to Genome Medical's telegenomics service model, with overlapping B2B and B2C channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@genomemedical
• LinkedInlinkedin.com/company/genome-medical
• Xx.com/genomemed
• Facebookfacebook.com/genomemedical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors22 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genome Medical